Eyes On Eyecare Optometry Facebook ad: “Designed with patients in mind”

Ran for 6 days, from July 24 to July 30, 2026, the last day Crush saw it.

Run by Eyes On Eyecare Optometry on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Want an ad like this for your product?

Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.

Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.

About this ad

Meta Ad Library ID: 1363987115934750
Platforms: Facebook, Instagram, Audience Network, WhatsApp and Threads
Relaunches: 0

How we count

Ad text

Qlosi demonstrated ciliary muscle movement similar to BSS (balanced salt solution) control proving pupil selectivity. Reference: Cabot F. Miotic eyedrops for presbyopia: Emerging therapies. Royal Hawaiian Eye Jan 2026. Paper presentation Indication and Usage - Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4%, for topical ophthalmic use is a cholinergic receptor agonist indicated for the treatment of presbyopia in adults. Important Safety Information: Contraindications – Hypersensitivity Adverse Reactions - The most common adverse reactions (5% to 8%) are instillation site pain and headaches. Please see full Prescribing Information here: qlosiecp.com/prescribing-information @2026 Orasis Pharmaceuticals, Inc. All Rights Reserved. | QLO.00509 | 01/2026

Where the ad sends people

https://qlosiecp.com/the-qlodown?utm_source=eyeson...

Designed with patients in mind

Empower your patients with once-or-twice-daily flexible dosing that actually fits their lifestyle.

See details: qlosiecp.com